Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell envelope and intracellular contents encompass the entire structural and functional apparatus of a bacterium, serving as the fundamental site of action for all antibacterial therapies. The cell envelope consists of the inner cytoplasmic membrane, the peptidoglycan cell wall, and, in Gram-negative bacteria, an additional outer membrane, all of which maintain osmotic pressure and regulate molecular transport (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). Within this envelope, the intracellular environment contains the genetic material (nucleoid), ribosomes for protein synthesis, and metabolic enzymes essential for growth and replication (Miller et al., 2014, Cold Spring Harb Perspect Med). Therapeutic intervention typically involves small molecules that exploit the biochemical differences between bacterial and eukaryotic cells, such as the unique structure of peptidoglycan or the specific sedimentation coefficients of bacterial ribosomes (Kohanski et al., 2010, Nat Rev Microbiol). Disruption of these components leads to bacteriostatic or bactericidal effects, making them the primary focus in treating infectious diseases ranging from minor skin infections to life-threatening sepsis. However, the complexity and adaptability of these structures contribute significantly to the global challenge of antimicrobial resistance, as bacteria evolve mechanisms to shield or modify these targets (Brown & Wright, 2016, Nature).
Antibacterial agents target these components through various pathways: beta-lactams and glycopeptides inhibit peptidoglycan synthesis in the cell wall; polymyxins and lipopeptides disrupt the integrity of the cytoplasmic or outer membranes; aminoglycosides, tetracyclines, and macrolides bind to ribosomal subunits to inhibit protein synthesis; and fluoroquinolones inhibit DNA topoisomerases within the intracellular space (Kohanski et al., 2010, Nat Rev Microbiol; Brown & Wright, 2016, Nature).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell envelope and intracellular contents.